Not applicableApproved For MarketingNCT04552691
What this trial is testing
Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease Patients
Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A.
Showing 20 of 0 results